- >=99.8 HPLCHPLC / MSIn stock
Research compound
NAD+
NAD+ (nicotinamide adenine dinucleotide, CAS 53-84-9) is the oxidized redox coenzyme that shuttles hydride equivalents through the core catabolic pathways — glycolysis, the TCA cycle, and mitochondrial electron transport — as part of the NAD+/NADH cycling mechanism. Its non-redox enzymatic roles are equally characterized: obligate co-substrate for SIRT1-7 deacylase reactions, ADP-ribose donor for PARP-mediated DNA damage response enzymes, and substrate for CD38/CD157 ectoenzyme-catalyzed cADPR synthesis. Valitec supplies NAD+ as a defined-purity reference for metabolic flux analysis, sirtuin deacylase assays, and NAD+ biosynthesis pathway characterization in cell-free and cellular systems. Supplied lyophilized for in vitro research use only.
Specification
- CAS
- 53-84-9
- Molecular weight
- 663.43 g/mol (anhydrous free acid)
- Formula
- C21H27N7O14P2
- Purity
- >=99.8 HPLC
- Storage
- -20 °C, lyophilized
Size
Research notes
What is NAD+?
NAD+ is a synthetic research compound studied in laboratory settings. It has molecular formula C21H27N7O14P2, a molecular weight of 663.43 g/mol (anhydrous free acid), CAS 53-84-9. It is intended for in vitro research use only and is not for human or animal use.
What purity is Valitec Peptides's NAD+?
Valitec Peptides supplies NAD+ at >=99.8% purity, verified by third-party HPLC analysis. A certificate of analysis is available on request.
How is NAD+ supplied?
NAD+ is supplied as a lyophilized powder in sealed research-grade vials, stored -20 °C, lyophilized, intended for in vitro and laboratory research use only.
For laboratory research use only. Not for human or veterinary use, and not for diagnostic or therapeutic use.